idarubicin has been researched along with Agranulocytosis in 10 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (10.00) | 18.7374 |
| 1990's | 5 (50.00) | 18.2507 |
| 2000's | 4 (40.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Du, X; Ke, XY; Liu, Y; Lu, ZS; Lv, JQ; Ma, J; Shen, ZX; Xu, XH; Zeng, XY; Zhan, ZM; Zhang, XH; Zhao, YM | 1 |
| Campbell, J; De La Serna, J; Diaz-Mediavilla, J; Francisco Tomás, J; García de Paredes, ML; Grande, C; Solano, C | 1 |
| Ohnishi, K; Ohno, R; Shinjyo, K; Takeshita, A; Tobita, T; Yanagi, M | 1 |
| Apel, D; Maj, S; Mariańska, B; Seferyńska, I | 1 |
| Aitini, E; Battista, R; Bendandi, M; Bocchia, M; Cellini, C; De Renzo, A; Fattori, PP; Gentilini, P; Gherlinzoni, F; Guardigni, L; Magagnoli, M; Moretti, L; Ronconi, F; Tura, S; Zaccaria, A; Zinzani, PL | 1 |
| Anderson, A; Cameron, DA; Howell, A; Leonard, RC; Ostrowski, J | 1 |
| Barbarano, L; Bernuzzi, P; Gargantini, L; Morra, E; Nosari, A; Pungolino, E; Santoleri, L | 1 |
| Nilsson, B; Rödjer, S; Westin, J | 1 |
| Case, DC; Crawford, J; Gams, RA; Gerber, MC; Gould, J; Higano, CS; Pruitt, BT; Votaw, ML | 1 |
| Kavanagh, JJ; Krakoff, IH; Savaraj, N; Yeung, KY | 1 |
7 trial(s) available for idarubicin and Agranulocytosis
| Article | Year |
|---|---|
[Multicenter randomized control trial on safety of domestic idarubicin for acute leukemia].
Topics: Adolescent; Adult; Aged; Agranulocytosis; Antibiotics, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; Blast Crisis; Cyclophosphamide; Cytarabine; Female; Humans; Idarubicin; Leukemia, Myeloid, Acute; Male; Middle Aged; Mucositis; Nausea; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Prednisone; Remission Induction; Treatment Outcome; Vincristine | 2006 |
Idarubicin and intermediate dose ARA-C followed by consolidation chemotherapy or bone marrow transplantation in relapsed or refractory acute myeloid leukemia.
Topics: Acute Disease; Adult; Agranulocytosis; Antibiotics, Antineoplastic; Bone Marrow Transplantation; Cytarabine; Disease-Free Survival; Dose-Response Relationship, Drug; Female; Humans; Idarubicin; Leukemia, Myeloid; Leukemia, Myeloid, Acute; Male; Nausea; Remission Induction; Thrombocytopenia; Treatment Outcome; Vomiting | 1997 |
[Preliminary treatment results of relapsed or refractory acute leukemia using two and three drug regimens].
Topics: Adult; Agranulocytosis; Antineoplastic Combined Chemotherapy Protocols; Cytarabine; Etoposide; Female; Humans; Idarubicin; Male; Middle Aged; Mitoxantrone; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Recurrence; Remission Induction | 1998 |
Fludarabine-based chemotherapy in untreated mantle cell lymphomas: an encouraging experience in 29 patients.
Topics: Adult; Aged; Agranulocytosis; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Female; Humans; Idarubicin; Lymphoma, Mantle-Cell; Male; Middle Aged; Prospective Studies; Recurrence; Risk Factors; Survival Rate; Treatment Outcome; Vidarabine | 1999 |
Idarubicin and cyclophosphamide--an active oral chemotherapy regimen for advanced breast cancer.
Topics: Administration, Oral; Adult; Aged; Agranulocytosis; Antibiotics, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Cyclophosphamide; Disease Progression; Fatigue; Female; Humans; Idarubicin; Infections; Middle Aged; Thrombocytopenia | 2000 |
Do anthracyclines have a role in the therapy of multiple myeloma?
Topics: Aged; Aged, 80 and over; Agranulocytosis; Antibiotics, Antineoplastic; Disease Progression; Female; Humans; Idarubicin; Male; Middle Aged; Multiple Myeloma; Recurrence; Remission Induction; Salvage Therapy; Thrombocytopenia; Treatment Failure | 2000 |
Phase II study of intravenous idarubicin in unfavorable non-Hodgkin's lymphoma.
Topics: Adult; Aged; Aged, 80 and over; Agranulocytosis; Drug Administration Schedule; Drug Evaluation; Female; Heart Diseases; Humans; Idarubicin; Infusions, Intravenous; Lymphoma, Non-Hodgkin; Male; Middle Aged | 1992 |
3 other study(ies) available for idarubicin and Agranulocytosis
| Article | Year |
|---|---|
Relapse in the external auditory canal of acute promyelocytic leukemia after treatment with all-trans retinoic acid.
Topics: Agranulocytosis; Antineoplastic Combined Chemotherapy Protocols; Biomarkers, Tumor; Combined Modality Therapy; Cytarabine; Daunorubicin; Ear Canal; Female; Granulocyte Colony-Stimulating Factor; Humans; Idarubicin; Leukemia, Promyelocytic, Acute; Mercaptopurine; Middle Aged; Mitoxantrone; Neoplasm Proteins; Oncogene Proteins, Fusion; Radiotherapy; Recurrence; Remission Induction; Salvage Therapy; Tretinoin; Vindesine | 1997 |
Treatment of patients with high-grade non-Hodgkin's lymphoma aged over 70 years with an all-oral regimen combining idarubicin, etoposide and alkylators.
Topics: Administration, Oral; Age Factors; Aged; Aged, 80 and over; Agranulocytosis; Alkylating Agents; Antineoplastic Combined Chemotherapy Protocols; Disease-Free Survival; Drug Evaluation; Etoposide; Female; Follow-Up Studies; Humans; Idarubicin; Lymphoma, Non-Hodgkin; Male; Prednimustine; Thrombocytopenia; Treatment Outcome | 2000 |
Phase I clinical evaluation of oral and intravenous 4-demethoxydaunorubicin.
Topics: Administration, Oral; Adult; Aged; Agranulocytosis; Antineoplastic Agents; Daunorubicin; Drug Evaluation; Female; Humans; Idarubicin; Injections, Intravenous; Male; Middle Aged; Neoplasms; Thrombocytopenia | 1985 |